Skip to main content

Table 4 The clinical characteristics of three patient with Niraparib treatment

From: Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer

  Age Type Bilateral ovaries FIGO CA125(Before) CA125(After) BRCA Tumor metastasis Surgery Chemotherapy
Patient 1 45 HGSC Yes IIIC 6.96 7.2 Wild No Yes Yes
Patient 2 58 HGSC Yes IV 13.2 12.3 Wild No Yes Yes
Patient 3 60 HGSC Yes IV 7.55 11.1 Wild No Yes Yes